Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo D Müller

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Nature Reviews. Endocrinology|December 13, 2025
Advances in incretin-based drug discovery in 2025Timo D Müller
Expert Review of Endocrinology & Metabolism|February 16, 2019
The potential of glucagon-like peptide 1 to reverse high-fat, high-sugar diet-related metabolic damageTimo D Müller
Diabetes|July 22, 2020
A New FGF21 Analog for the Treatment of Fatty Liver DiseaseMaximilian Kleinert, Timo D Müller
International Journal of Molecular Sciences|January 16, 2020
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon"Timo D Müller, Kirk Habegger
Peptides|March 25, 2024
Regulation of energy metabolism through central GIPR signalingArkadiusz Liskiewicz, Timo D Müller
Nature Reviews. Endocrinology|June 9, 2025
Tirzepatide differentially affects body weight in mice and humansAaron Novikoff, Timo D Müller
Molecular Metabolism|April 22, 2014
Relationship status update for PTP1B and LepR: It׳s complicatedKatrin Fischer, Timo D Müller
Med (New York, N.Y.)|December 9, 2023
SURMOUNTing body weight barriers in type 2 diabetesAaron Novikoff, Timo D Müller
Nature Metabolism|July 23, 2020
Teaching an old dog new tricks: metformin induces body-weight loss via GDF15Maximilian Kleinert, Timo D Müller
Physiology (Bethesda, Md.)|February 14, 2024
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don'tAaron Novikoff, Timo D Müller
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Nature Reviews. Endocrinology|December 13, 2025
Advances in incretin-based drug discovery in 2025Timo D Müller
Expert Review of Endocrinology & Metabolism|February 16, 2019
The potential of glucagon-like peptide 1 to reverse high-fat, high-sugar diet-related metabolic damageTimo D Müller
Diabetes|July 22, 2020
A New FGF21 Analog for the Treatment of Fatty Liver DiseaseMaximilian Kleinert, Timo D Müller
International Journal of Molecular Sciences|January 16, 2020
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon"Timo D Müller, Kirk Habegger
Peptides|March 25, 2024
Regulation of energy metabolism through central GIPR signalingArkadiusz Liskiewicz, Timo D Müller
Nature Reviews. Endocrinology|June 9, 2025
Tirzepatide differentially affects body weight in mice and humansAaron Novikoff, Timo D Müller
Molecular Metabolism|April 22, 2014
Relationship status update for PTP1B and LepR: It׳s complicatedKatrin Fischer, Timo D Müller
Med (New York, N.Y.)|December 9, 2023
SURMOUNTing body weight barriers in type 2 diabetesAaron Novikoff, Timo D Müller
Nature Metabolism|July 23, 2020
Teaching an old dog new tricks: metformin induces body-weight loss via GDF15Maximilian Kleinert, Timo D Müller
Physiology (Bethesda, Md.)|February 14, 2024
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don'tAaron Novikoff, Timo D Müller
Pageof 19